Evidence map›Paper›PMID 37818185›Full record

ReviewFrontiers in pharmacology2023

Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review.

Xianguang Deng, Juan Wang, Chenyi Lu, Yao Zhou, Lele Shen, Anqi Ge, Hongqiao Fan, Lifang Liu

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xianguang DengDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Juan WangDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Chenyi LuDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Yao ZhouDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Lele ShenDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Anqi GeDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Hongqiao FanDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Lifang LiuDepartment of Galactophore, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
First Affiliated Hospital of Hunan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is currently the most common malignancy and has a high mortality rate. Ginsenosides, the primary bioactive constituents of ginseng, have been shown to be highly effective against breast cancer both

Indexed as

bibliometricsbreast cancerginsengginsenosidesreview

Identifiers

PMID37818185
PMCPMC10560733
OpenAlexW4387052548

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.